| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | Common Stock | Options Exercise | $1,632,255 | +31,002 | +37% | $52.65 | 114,018 | 05 Feb 2024 | Direct | F1, F2 |
| transaction | RVTY | Common Stock | Sale | $1,534,633 | -14,749 | -13% | $104.05 | 99,269 | 05 Feb 2024 | Direct | F3 |
| transaction | RVTY | Common Stock | Sale | $677,846 | -6,468 | -6.5% | $104.80 | 92,801 | 05 Feb 2024 | Direct | F4 |
| transaction | RVTY | Common Stock | Options Exercise | $2,750,028 | +26,037 | +28% | $105.62 | 118,838 | 05 Feb 2024 | Direct | F5 |
| transaction | RVTY | Common Stock | Tax liability | $1,183,895 | -11,209 | -9.4% | $105.62 | 107,629 | 05 Feb 2024 | Direct | F6 |
| transaction | RVTY | Common Stock | Tax liability | $445,188 | -4,215 | -3.9% | $105.62 | 103,414 | 05 Feb 2024 | Direct | F7 |
| holding | RVTY | Common Stock | 25,088 | 05 Feb 2024 | By Singh Family Trust of 2021 | F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RVTY | NQ Stock Option (right to buy) | Options Exercise | $0 | -31,002 | -100% | $0.000000* | 0 | 05 Feb 2024 | Common Stock | 31,002 | $52.65 | Direct | F2, F9 |
| transaction | RVTY | NQ Stock Option (right to buy) | Award | $0 | +110,111 | $0.000000 | 110,111 | 05 Feb 2024 | Common Stock | 110,111 | $104.64 | Direct | F10 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | The transactions reported above in Table I include a cashless exercise of stock options. The cashless exercise for the stock options is reported in three lines. The first line of the cashless exercise transaction is coded M in column 3 of Table I and reports in column 4 the number of shares issuable upon exercise of the options had cash been paid to exercise the options, together with the exercise price with Code A for acquired. The second and third lines coded S in column 3 of Table I relate to the same cashless exercise on the first line in Table I and report in Column 4 the number of shares sold from the total number of shares issuable to pay for the cashless exercise of such options with Code D for disposed. The transaction reported in Table II line one above, reflects the disposition of the same stock options whose cashless exercise is disclosed in Table I above. The foregoing transactions were effected pursuant to a 10b5-1 trading plan adopted by Mr. Singh on August 4, 2023. |
| F2 | The Exercise Price included on the Form 4 filed on February 8, 2017 for the Reporting Person was incorrectly reported due to administrative error. |
| F3 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $103.55 to $104.54. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F4 | The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $104.55 to $105.49. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| F5 | Shares of common stock issued upon vesting of performance-based restricted stock units in accordance with the terms of a Performance-based Restricted Stock Unit award originally granted on February 5, 2021. |
| F6 | These shares are being surrendered to satisfy a tax withholding obligation upon vesting of performance-based restricted stock units originally granted on February 5, 2021, as required by the Reporting Person's Performance-based Restricted Stock Unit Agreement. |
| F7 | These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2021, as required by the Reporting Person's Restricted Stock Agreement. |
| F8 | Securities held in an irrevocable trust for the sole benefit of the reporting person's children. The reporting person's spouse is the trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F9 | This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. |
| F10 | This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. |
President, Chief Executive Officer and Director